Yoshua Quinones

Internal Medicine physician in New York, New York — also lists obesity medicine in the CMS registry.

Practice Details

Address
112 W 72nd St
New York, NY 10023
Geocoded location: 40.7775, -73.9792
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2019
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
July 2023

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Surgery
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Yoshua Quinones is an Internal Medicine physician in New York whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 4218 Internal Medicine practices in New York carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Yoshua Quinones's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 332-456-9738.

GLP-1 access in New York, New York

Adult obesity rate
28.9%
#41 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical New York telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New York Medicaid, obesity indication

About 28.9% of New York adults have obesity (BMI 30+), ranking the state #41 of 50 (CDC BRFSS). Our directory currently lists 540 GLP-1-relevant clinics in New York. If a cash-pay route makes more sense, compounded semaglutide through New York telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more New York options on the best New York GLP-1 providers page, browse every New York listing in the New York clinic directory.

Related Practices in New York

Other New York listings in the same directory tier:

Xequiel Hernandez
Family Medicine
Xavier Pi-Sunyer
Internal Medicine
Steven Greer
General Practice

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New York addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New York telehealth partners:

Featured Partners · New York

Featured GLP-1 providers serving New York

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 184 GLP-1 providers serving New York ↓

See more New York options on the New York clinic directory, our New York GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by New York obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Yoshua Quinones's specialty taxonomy but not the specific medications it prescribes or its current service menu. Yoshua Quinones is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 332-456-9738 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Yoshua Quinones's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Yoshua Quinones is located at 112 W 72nd St, New York, NY 10023. The phone number listed in the registry is 332-456-9738. Its full record is public in the CMS National Provider registry under NPI 1730643586.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Yoshua Quinones is currently accepting new patients. Call the practice at 332-456-9738 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.